Skip to main content
Thomas Montine, MD, Pathology, Stanford, CA

ThomasJMontineMD

Pathology • Stanford, CA

Neuropathology, Anatomic Pathology

Physician

Join to view full profile

Dr. Montine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Montine's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Stanford, CA 94305
    Phone+1 650-723-4000

Education & Training

  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1991
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2025
  • WA State Medical License
    WA State Medical License 2002 - 2024
  • TN State Medical License
    TN State Medical License 1995 - 2004
  • NC State Medical License
    NC State Medical License 1993 - 1996
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Neuropathology

Publications & Presentations

PubMed

Lectures

  • 41st Annual Update in Family Practice and Primary Care 
    University of Washington School of Medicine, Seattle, Washington - 9/9/2013

Press Mentions

  • Despite Concerns, FDA Panel Reverses Course of ALS Drug and Recommends Approval: Shots
    Despite Concerns, FDA Panel Reverses Course of ALS Drug and Recommends Approval: ShotsSeptember 21st, 2022
  • FDA Seems Poised to Approve a New Drug for ALS, but Does It Work?
    FDA Seems Poised to Approve a New Drug for ALS, but Does It Work?September 21st, 2022
  • Despite Concerns, FDA Panel Reverses ALS Drug Course, Recommends Approval: Vaccines
    Despite Concerns, FDA Panel Reverses ALS Drug Course, Recommends Approval: VaccinesSeptember 21st, 2022
  • Join now to see all

Grant Support

  • Alzheimer'S Disease Research CenterNational Institute On Aging2012
  • Neuropathology And Targeted Molecular Testing CoreNational Institute On Aging2010–2012
  • CSF Proteome Of Geriatric Dementia: CSF Protein Profiling Of CNS Insulin ActivityNational Institute On Aging2010–2012
  • Selective And Restricted Denervation In Parkinson'S Disease With Cognitive ImpairNational Institute Of Neurological Disorders And Stroke2009–2011
  • Pacific Northwest Udall CenterNational Institute Of Neurological Disorders And Stroke2009–2011
  • Administrative And OutreachNational Institute Of Neurological Disorders And Stroke2009–2011
  • Toxicants And Innate Immunity In Models Of Parkinson'S DiseaseNational Institute Of Environmental Health Sciences2009–2011
  • Environmental Pathology/Toxicology Training ProgramNational Institute Of Environmental Health Sciences2008–2011
  • White Matter Damage In Age-Related Cognitive DeclineNational Institute On Aging2009–2010
  • Pharmaconeuropathology Of Brain Aging And DementiaNational Institute On Aging2005–2009
  • CSF Proteome Of Geriatric DementiaNational Institute On Aging2005–2009
  • Core--NeuropathologyNational Institute On Aging2005–2009
  • Proteomic Discovery In Parkinson-Dementia Complex Of GuamNational Institute On Aging2007–2008
  • Characterization Of Dementia With Lewy Bodies: A Collaborative StudyNational Institute Of Neurological Disorders And Stroke2007
  • Lipid Oxidation Products In Alzheimer'S DiseaseNational Institute On Aging2003–2007
  • Dementia With Lewy Bodies: A Collaborative StudyNational Institute Of Neurological Disorders And Stroke2003–2006
  • Catechol Thioethers In Parkinson'S DiseaseNational Institute Of Environmental Health Sciences2002–2004
  • Lipid Peroxidation And APOE In Alzheimers DiseaseNational Institute On Aging2002–2003
  • Dendritic Spines In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2002
  • Catechol Thioethers In Parkinson'S DiseaseNational Institute Of Environmental Health Sciences2000–2002
  • Quantification Of Brain Oxidative Damage In Alzheimer'S Disease PatientsNational Center For Research Resources2000–2002
  • Lipid Peroxidation And APOE In Alzheimers DiseaseNational Institute On Aging1999–2002
  • Lipid Peroxidation, Antioxidants In ADNational Institute On Aging2000
  • Crosslinking Of APOE And TAU In Alzheimers DiseaseNational Institute On Aging1996–2000
  • Toxicant Enhanced Autoxidation Of DOPA And DopamineNational Institute Of Environmental Health Sciences1994
  • Toxicant-Enhanced Autoxidation Of DOPA And DopamineNational Institute Of Environmental Health Sciences1993

Dr. Thomas Montine, Dr. Thomas Montine, MD, Dr. T Montine, Dr. Thomas J Montine